AUPH

Q: What is the price of Aurinia Pharmaceuticals (AUPH) today?

The price of Aurinia Pharmaceuticals (AUPH) today is $ 16.25, with return of 76.63% compared to the last year. The price of Aurinia Pharmaceuticals (AUPH) started the year trading around $ 8.98 and today it is at $ 16.25. Follow the real-time price chart, the historical price of Aurinia Pharmaceuticals (AUPH) and international markets.

Q: When does Aurinia Pharmaceuticals (AUPH) pay dividends?

Aurinia Pharmaceuticals (AUPH) did not distribute dividends in the last year.

Q: Is Aurinia Pharmaceuticals (AUPH) worth it?

Currently, Aurinia Pharmaceuticals (AUPH) is priced at $ 16.25, with a P/E of 27.56%, representing a deviation of 4,299% from its historical average P/E. In the last year, the stock showed a variation of 76.63 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 76.63%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Aurinia Pharmaceuticals (AUPH) stock?

Investing in stocks of Aurinia Pharmaceuticals (AUPH) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Aurinia Pharmaceuticals (AUPH) yield today?

The yield of Aurinia Pharmaceuticals (AUPH) was 0.81% in the last month, 76.63% in the last year and 16.40% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Aurinia Pharmaceuticals (AUPH) today, the total investment would be $ 1,625.00, based on the current price of $ 16.25.If past performance were to repeat, the return on your investment would be:In 1 year: $ 2,870.24In 5 years: $ 1,891.50In 10 years: $ 11,002.55It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Aurinia Pharmaceuticals Inc.

Price

$ 16.25

return (12m)

76.63%

p/e

27.56

p/bv

5.86

DIVIDEND YIELD

0.00%

price AUPH

AUPH

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of AUPH

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.81%

3 months

46.93%

1 year

76.63%

2 years

80.76%

5 years

16.40%

10 years

577.08%

Fundamentals AUPH

review the fundamentals of Aurinia Pharmaceuticals shares

P/E

27.56

Sector: -3.69 Industry: -3.69

P/SALES RATIO (PSR)

8.07

Sector: -3.67 Industry: -3.67

P/BV

5.86

Sector: 2.06 Industry: 2.06

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

14.75%

Sector: -63.57% Industry: -63.57%

ROE

21.28%

Sector: -66.84% Industry: -66.84%

ROIC

90.91%

Sector: -1,129.00% Industry: -1,129.00%

NET MARGIN

29.28%

Sector: -41.13% Industry: -41.13%

GROSS MARGIN

88.92%

Sector: 39.22% Industry: 39.22%

OPERATING MARGIN

32.73%

Sector: -40.98% Industry: -40.98%

P/EBITDA

20.72

Sector: -3.65 Industry: -3.65

P/EBIT

25.51

Sector: -3.78 Industry: -3.78

P/ASSET

4.07

Sector: 1.47 Industry: 1.47

BVPS

2.77

Sector: 1.77 Industry: 1.77

EPS

0.59

Sector: -2.04 Industry: -2.04

EQUITY RATIO

0.69

Sector: 0.41 Industry: 0.41

CAGR REVENUE 5 YEARS

39.61%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

FAIR VALUE OF Aurinia Pharmaceuticals ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 16.25

Fair Value

$ 0.00

Upside Return potential.

-62.68%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals AUPH

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	19.90	6.31	31.69%	2.48%	$ 499.97 B	27.26%
PFE	14.51	1.53	10.56%	6.86%	$ 142.64 B	15.65%
ABBV	168.68	-154.98	-91.88%	2.88%	$ 402.80 B	4.00%
NVO	15.11	8.72	57.70%	3.22%	$ 232.87 B	32.78%
MRK	14.01	0.00	0.00%	3.03%	$ 266.74 B	29.63%
AZN	30.66	6.27	20.45%	1.68%	$ 288.18 B	16.17%
BMY	18.42	5.98	32.47%	4.54%	$ 111.25 B	12.57%
GILD	18.99	7.18	37.80%	2.53%	$ 153.99 B	27.88%
ZTS	21.09	10.36	49.11%	1.58%	$ 55.92 B	28.21%
HALO	13.53	15.99	118.17%	0.00%	$ 8.06 B	47.91%
REGN	17.83	2.64	14.79%	0.45%	$ 81.64 B	32.13%
AMGN	25.57	18.62	72.82%	2.86%	$ 179.12 B	19.47%
VRTX	32.24	6.84	21.22%	0.00%	$ 118.50 B	31.35%
MCK	25.44	-177.52	-697.75%	0.36%	$ 102.61 B	1.04%
CAH	31.08	-18.15	-58.40%	0.98%	$ 49.57 B	0.68%
ADMA	22.00	10.69	48.57%	0.00%	$ 4.61 B	42.87%
BIIB	16.18	1.43	8.83%	0.00%	$ 26.03 B	15.98%
HRMY	11.91	2.65	22.24%	0.00%	$ 2.21 B	22.48%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

AUPH Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY Aurinia Pharmaceuticals

Aurinia Pharmaceuticals Inc.

Average user rating I10

4.0 (1 people)

United States

14 years

Founded: 2011

2009

Time since IPO - 16 years

62

Employees

The Company Aurinia Pharmaceuticals Inc. (United States), is listed on Nasdaq with a market value of $ 2.15 Billions, having an equity of $ 365.77 Millions.

With a total of 62 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 265.82 Millions, which generated a profit in the amount of $ 77.83 Millions.

As for its main indicators, the Company has a P/E ratio of 27.56, a P/BV ratio of 5.86 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker AUPH.

Market cap

$ 2.15 Billions

Net worth

$ 365.77 Millions

US$ 365,770,000.00

Assets

$ 527.53 Millions

US$ 527,530,000.00

Total Shares Outstanding

132.00 Millions

132,000,000

Average Daily Trading Volume

$ 1.63 Million

US$ 1,626,040.00

Sector

Health Care

Industry

Biotechnology

AUPH

AUPH revenue and profits

Financial Results AUPH

DRAG THE FRAME TO SEE MORE DATA

AUPH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 828.26 44,41% (12M)

P/E

25.44

0.36%

ROE

-697.75%

P/BV

-177.52

CAH - Cardinal Health

$ 208.29 77,78% (12M)

P/E

31.08

0.98%

ROE

-58.40%

P/BV

-18.15

JNJ - Johnson & Johnson

$ 207.63 47,53% (12M)

P/E

19.90

2.48%

ROE

31.69%

P/BV

6.31

MRK - Merck & Co.

$ 106.78 12,02% (12M)

P/E

14.01

3.03%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.09 3,61% (12M)

P/E

14.51

6.86%

ROE

10.56%

P/BV

1.53

ABBV - AbbVie

$ 229.98 34,74% (12M)

P/E

168.68

2.88%

ROE

-91.88%

P/BV

-154.98

AZN - AstraZeneca

$ 92.90 43,20% (12M)

P/E

30.66

1.68%

ROE

20.45%

P/BV

6.27

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 828.26 44,41% (12 M)

P/L

25.44

0.36%

ROE

-697.75%

P/VP

-177.52

CAH - Cardinal Health

$ 208.29 77,78% (12 M)

P/L

31.08

0.98%

ROE

-58.40%

P/VP

-18.15

JNJ - Johnson & Johnson

$ 207.63 47,53% (12 M)

P/L

19.90

2.48%

ROE

31.69%

P/VP

6.31

MRK - Merck & Co.

$ 106.78 12,02% (12 M)

P/L

14.01

3.03%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.09 3,61% (12 M)

P/L

14.51

6.86%

ROE

10.56%

P/VP

1.53

ABBV - AbbVie

$ 229.98 34,74% (12 M)

P/L

168.68

2.88%

ROE

-91.88%

P/VP

-154.98

AZN - AstraZeneca

$ 92.90 43,20% (12 M)

P/L

30.66

1.68%

ROE

20.45%

P/VP

6.27

Frequently Asked Questions

What is the price of Aurinia Pharmaceuticals (AUPH) today?

The price of Aurinia Pharmaceuticals (AUPH) today is $ 16.25, with return of 76.63% compared to the last year. The price of Aurinia Pharmaceuticals (AUPH) started the year trading around $ 8.98 and today it is at $ 16.25. Follow the real-time price chart, the historical price of Aurinia Pharmaceuticals (AUPH) and international markets.

When does Aurinia Pharmaceuticals (AUPH) pay dividends?

Aurinia Pharmaceuticals (AUPH) did not distribute dividends in the last year.

Is Aurinia Pharmaceuticals (AUPH) worth it?

Currently, Aurinia Pharmaceuticals (AUPH) is priced at $ 16.25, with a P/E of 27.56%, representing a deviation of 4,299% from its historical average P/E. In the last year, the stock showed a variation of 76.63 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 76.63%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Aurinia Pharmaceuticals (AUPH) stock?

Investing in stocks of Aurinia Pharmaceuticals (AUPH) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Aurinia Pharmaceuticals (AUPH) yield today?

The yield of Aurinia Pharmaceuticals (AUPH) was 0.81% in the last month, 76.63% in the last year and 16.40% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Aurinia Pharmaceuticals (AUPH) today, the total investment would be $ 1,625.00, based on the current price of $ 16.25.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 2,870.24
In 5 years: $ 1,891.50
In 10 years: $ 11,002.55

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

AUPH

Aurinia Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of AUPH

review the fundamentals of Aurinia Pharmaceuticals shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY Aurinia Pharmaceuticals

Aurinia Pharmaceuticals Inc.

United States

14 years

2009

62

PROFIT X PRICE AUPH

Financial Results AUPH

AUPH cash flow

asset growth - AUPH

AUPH balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions